<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2025"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:vavx="http://www.vaneck.com/20251231"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="vavx-20251231.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
        </entity>
        <period>
            <instant>2026-02-28</instant>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
        </entity>
        <period>
            <startDate>2025-11-20</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
        </entity>
        <period>
            <instant>2025-11-19</instant>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vavx:QuantityOfAvaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-19</instant>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:PortionAtFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-19</instant>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vavx:QuantityOfAvaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-20</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:PortionAtFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-20</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vavx:QuantityOfAvaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:PortionAtFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-26</startDate>
            <endDate>2026-01-26</endDate>
        </period>
    </context>
    <context id="c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-28</startDate>
            <endDate>2026-02-28</endDate>
        </period>
    </context>
    <context id="c17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vavx:SeedCapitalInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-20</startDate>
            <endDate>2025-11-20</endDate>
        </period>
    </context>
    <context id="c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vavx:SeedCapitalInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-20</instant>
        </period>
    </context>
    <context id="c19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vavx:SeedCapitalInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-20</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vavx:SeedCreationBasketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-22</instant>
        </period>
    </context>
    <context id="c21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vavx:SeedCreationBasketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-22</startDate>
            <endDate>2025-12-22</endDate>
        </period>
    </context>
    <context id="c22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vavx:SeedCapitalInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vavx:SecondaryMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">vavx:CoinbaseCustodyTrustCompanyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Avalanche">
        <measure>vavx:Avalanche</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="Segment">
        <measure>vavx:Segment</measure>
    </unit>
    <dei:DocumentType contextRef="c0" id="ixv-7184">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="c0" id="ixv-31">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c0" id="ixv-7185">2025-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c0" id="ixv-7186">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c0" id="ixv-7187">2025</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="c0" id="ixv-47">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c0" id="ixv-7188">001-43064</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-7189">VANECK AVALANCHE ETF</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0" id="ixv-76">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c0" id="ixv-80">33-6867966</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c0" id="ixv-7190">666 Third Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c0" id="ixv-7191">9th Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c0" id="ixv-7192">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c0" id="ixv-7193">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c0" id="ixv-7194">10017</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c0" id="ixv-7195">212</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c0" id="ixv-7196">293-2048</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c0" id="ixv-131">Shares</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c0" id="ixv-134">VAVX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c0" id="ixv-137">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c0" id="ixv-7197">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c0" id="ixv-7198">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c0" id="ixv-7199">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c0" id="ixv-7200">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c0" id="ixv-7201">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c0" id="ixv-204">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c0" id="ixv-207">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c0" id="ixv-213">true</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag contextRef="c0" id="ixv-219">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c0" id="ixv-225">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="c0" id="ixv-237">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="c1" decimals="0" id="ixv-7202" unitRef="usd">0</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="c2"
      decimals="INF"
      id="ixv-7203"
      unitRef="shares">575000</dei:EntityCommonStockSharesOutstanding>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock contextRef="c0" id="ixv-5038">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Risk Management, Strategy, and Governance&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Trust has no employees or internal information
systems and is managed by the Sponsor. Thus, the Trust relies on the Sponsor and VanEck, the parent company of the Sponsor, as well as
the AVAX Custodian and other service providers to protect the Trust&#x2019;s information from cybersecurity threats. VanEck has policies,
standards, and procedures on information security (the &#x201c;Cybersecurity Documents&#x201d;). The Cybersecurity Documents govern the
procurement, use, storage, protection and permissions of data systems, applications and devices. The Cybersecurity Documents outline the
correct usage of elements and tasks on the networks/infrastructure to ensure safe operation, high availability, performance, and data
accuracy.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;VanEck has adopted the National Institute of Standards
and Technology&#x2019;s (&#x201c;NIST&#x201d;) cybersecurity framework as its security outline. The program is reviewed annually. Using the
NIST framework as a guide, VanEck&#x2019;s cybersecurity program is organized around the following program domains:&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 18pt"&gt;&lt;/td&gt;&lt;td style="width: 18pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Identify critical assets, data, systems and capabilities, cybersecurity strategy and governing elements,
threats, and cybersecurity risks&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 18pt"&gt;&lt;/td&gt;&lt;td style="width: 18pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Protect assets (data, systems, networks, personnel, etc.) from external or internal malicious actors and
failed practices&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 18pt"&gt;&lt;/td&gt;&lt;td style="width: 18pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Detect anomalies and security events through environments monitoring, analysis, remediation, and reporting.
Engage outside vendors to periodically test the network infrastructure and software applications against known vulnerabilities and to
ensure the use of a best practice security program&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 18pt"&gt;&lt;/td&gt;&lt;td style="width: 18pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Respond to incidents regardless of source or causality&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 18pt"&gt;&lt;/td&gt;&lt;td style="width: 18pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Recover through planning, improvements, and communications (external and internal)&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 18pt"&gt;&lt;/td&gt;&lt;td style="width: 18pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Conduct after-action evaluation to identify what went well, what did not go well and improve VanEck systems
on the back of an issue&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;VanEck employs third-party firms to assess its
cybersecurity posture, conduct penetration testing, and forensic analysis.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;VanEck maintains a risk-based approach to identifying
and overseeing cybersecurity risks presented by third parties, including vendors, service providers, counterparties, and clients, as well
as the systems of third parties that could significantly and adversely impact VanEck&#x2019;s business in the event of a cybersecurity
incident affecting those third-party systems. Third-party risks are included within VanEck&#x2019;s NIST framework, and risk identification
and mitigation are supported by VanEck&#x2019;s cybersecurity program. VanEck also performs diligence on certain third parties and monitors
cybersecurity threats and risks identified through such diligence.&lt;/p&gt;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock contextRef="c0" id="ixv-7204">The Trust has no employees or internal information
systems and is managed by the Sponsor. Thus, the Trust relies on the Sponsor and VanEck, the parent company of the Sponsor, as well as
the AVAX Custodian and other service providers to protect the Trust&#x2019;s information from cybersecurity threats.</cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag contextRef="c0" id="ixv-7205">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock contextRef="c0" id="ixv-7206">VanEck has adopted the National Institute of Standards
and Technology&#x2019;s (&#x201c;NIST&#x201d;) cybersecurity framework as its security outline.</cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag contextRef="c0" id="ixv-5123">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag contextRef="c0" id="ixv-5125">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock contextRef="c0" id="ixv-5136">&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Roles and Responsibilities&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Roles and responsibilities for cybersecurity have
been established first by VanEck&#x2019;s cybersecurity policy and secondly by its connection to the governance structure of the firm and
VanEck&#x2019;s risk management committee (the &#x201c;Risk Management Committee&#x201d;), which is comprised of senior-level employees.
Cybersecurity is closely aligned with not only risk management, but also with business continuity planning and response. In addition,
the importance of cybersecurity protection and its practice at the manager and employee level is frequently communicated to the staff
globally. Specifically, VanEck&#x2019;s Chief Information Security Officer, reporting to the co-chair of the Risk Management Committee,
is responsible for conducting the firm&#x2019;s cybersecurity risk assessment, as well as providing regular staff educations with a special
emphasis on proper desktop and email security and conduct. Special training is also given to recently on-boarded staff. VanEck&#x2019;s
Chief Administrative Officer and Chief Technology Officer, together with VanEck&#x2019;s Chief Information Security Officer, are responsible
for the day-to-day operations of the firm cybersecurity infrastructure including normal operations as well as any remedial work required
in response to an incident. The communication responsibility in the event of an incident is shared by VanEck&#x2019;s CEO and the General
Counsel.&lt;/p&gt;</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskRoleOfManagementTextBlock contextRef="c0" id="ixv-5142">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Roles and responsibilities for cybersecurity have
been established first by VanEck&#x2019;s cybersecurity policy and secondly by its connection to the governance structure of the firm and
VanEck&#x2019;s risk management committee (the &#x201c;Risk Management Committee&#x201d;), which is comprised of senior-level employees.
Cybersecurity is closely aligned with not only risk management, but also with business continuity planning and response. In addition,
the importance of cybersecurity protection and its practice at the manager and employee level is frequently communicated to the staff
globally. Specifically, VanEck&#x2019;s Chief Information Security Officer, reporting to the co-chair of the Risk Management Committee,
is responsible for conducting the firm&#x2019;s cybersecurity risk assessment, as well as providing regular staff educations with a special
emphasis on proper desktop and email security and conduct. Special training is also given to recently on-boarded staff. VanEck&#x2019;s
Chief Administrative Officer and Chief Technology Officer, together with VanEck&#x2019;s Chief Information Security Officer, are responsible
for the day-to-day operations of the firm cybersecurity infrastructure including normal operations as well as any remedial work required
in response to an incident. The communication responsibility in the event of an incident is shared by VanEck&#x2019;s CEO and the General
Counsel.&lt;/p&gt;</cyd:CybersecurityRiskRoleOfManagementTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock contextRef="c0" id="ixv-7207">Specifically, VanEck&#x2019;s Chief Information Security Officer, reporting to the co-chair of the Risk Management Committee,
is responsible for conducting the firm&#x2019;s cybersecurity risk assessment, as well as providing regular staff educations with a special
emphasis on proper desktop and email security and conduct. Special training is also given to recently on-boarded staff.</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag contextRef="c0" id="ixv-7208">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag contextRef="c0" id="ixv-7209">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag>
    <cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock contextRef="c0" id="ixv-7210">VanEck&#x2019;s
Chief Administrative Officer and Chief Technology Officer, together with VanEck&#x2019;s Chief Information Security Officer, are responsible
for the day-to-day operations of the firm cybersecurity infrastructure including normal operations as well as any remedial work required
in response to an incident. The communication responsibility in the event of an incident is shared by VanEck&#x2019;s CEO and the General
Counsel.</cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c0" id="ixv-7211">VanEck&#x2019;s
Chief Administrative Officer and Chief Technology Officer, together with VanEck&#x2019;s Chief Information Security Officer, are responsible
for the day-to-day operations of the firm cybersecurity infrastructure including normal operations as well as any remedial work required
in response to an incident.</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c0" id="ixv-7212">VanEck&#x2019;s
Chief Administrative Officer and Chief Technology Officer, together with VanEck&#x2019;s Chief Information Security Officer, are responsible
for the day-to-day operations of the firm cybersecurity infrastructure including normal operations as well as any remedial work required
in response to an incident.</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock contextRef="c0" id="ixv-7213">Since our commencement of operations, we have
not experienced a material information security breach incident and we are not aware of any cybersecurity risks that are reasonably likely
to materially affect our business. However, future incidents could have a material impact on our business strategy, results of operations,
or financial condition.</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag contextRef="c0" id="ixv-7214">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c0" id="ixv-7215">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c0" id="ixv-7216">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c0" id="ixv-7217">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c0" id="ixv-7218">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c0" id="ixv-7219">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <dei:AuditorFirmId contextRef="c0" id="ixv-7220">925</dei:AuditorFirmId>
    <dei:AuditorName contextRef="c0" id="ixv-7221">Cohen &amp; Company, LTD.</dei:AuditorName>
    <dei:AuditorLocation contextRef="c0" id="ixv-7222">Towson, Maryland</dei:AuditorLocation>
    <us-gaap:CryptoAssetCost contextRef="c3" decimals="0" id="ix_1_fact" unitRef="usd">2500000</us-gaap:CryptoAssetCost>
    <us-gaap:CryptoAssetFairValue contextRef="c3" decimals="0" id="ix_0_fact" unitRef="usd">2517563</us-gaap:CryptoAssetFairValue>
    <us-gaap:Assets contextRef="c3" decimals="0" id="ix_2_fact" unitRef="usd">2517563</us-gaap:Assets>
    <vavx:AccruedSponsorFee contextRef="c3" decimals="0" id="ix_3_fact" unitRef="usd">0</vavx:AccruedSponsorFee>
    <us-gaap:Liabilities contextRef="c3" decimals="0" id="ix_4_fact" unitRef="usd">0</us-gaap:Liabilities>
    <us-gaap:AssetsNet contextRef="c3" decimals="0" id="ix_5_fact" unitRef="usd">2517563</us-gaap:AssetsNet>
    <us-gaap:CommonStockNoParValue
      contextRef="c3"
      decimals="INF"
      id="ix_8_fact"
      unitRef="usdPershares">0</us-gaap:CommonStockNoParValue>
    <us-gaap:SharesOutstanding
      contextRef="c3"
      decimals="INF"
      id="ix_6_fact"
      unitRef="shares">100000</us-gaap:SharesOutstanding>
    <us-gaap:SharesIssued
      contextRef="c3"
      decimals="INF"
      id="ix_7_fact"
      unitRef="shares">100000</us-gaap:SharesIssued>
    <us-gaap:NetAssetValuePerShare
      contextRef="c3"
      decimals="INF"
      id="ix_9_fact"
      unitRef="usdPershares">25.18</us-gaap:NetAssetValuePerShare>
    <us-gaap:SponsorFees contextRef="c4" decimals="0" id="ix_10_fact" unitRef="usd">0</us-gaap:SponsorFees>
    <us-gaap:OperatingExpenses contextRef="c4" decimals="0" id="ix_11_fact" unitRef="usd">0</us-gaap:OperatingExpenses>
    <us-gaap:InvestmentCompanyExpenseOffsetArrangement contextRef="c4" decimals="0" id="ix_12_fact" unitRef="usd">0</us-gaap:InvestmentCompanyExpenseOffsetArrangement>
    <us-gaap:InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement contextRef="c4" decimals="0" id="ix_13_fact" unitRef="usd">0</us-gaap:InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement>
    <us-gaap:NetInvestmentIncome contextRef="c4" decimals="0" id="ix_14_fact" unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <vavx:NetRealizedGainLossOnEtherDistributedForSponsorFeeRelatedParty contextRef="c4" decimals="0" id="ix_15_fact" unitRef="usd">0</vavx:NetRealizedGainLossOnEtherDistributedForSponsorFeeRelatedParty>
    <us-gaap:CryptoAssetRealizedGainLossOperatingAndNonoperating contextRef="c4" decimals="0" id="ix_16_fact" unitRef="usd">0</us-gaap:CryptoAssetRealizedGainLossOperatingAndNonoperating>
    <us-gaap:CryptoAssetUnrealizedGainLossOperatingAndNonoperating contextRef="c4" decimals="0" id="ix_17_fact" unitRef="usd">17563</us-gaap:CryptoAssetUnrealizedGainLossOperatingAndNonoperating>
    <us-gaap:CryptoAssetRealizedAndUnrealizedGainLossOperatingAndNonoperating contextRef="c4" decimals="0" id="ix_18_fact" unitRef="usd">17563</us-gaap:CryptoAssetRealizedAndUnrealizedGainLossOperatingAndNonoperating>
    <us-gaap:NetIncomeLoss contextRef="c4" decimals="0" id="ix_19_fact" unitRef="usd">17563</us-gaap:NetIncomeLoss>
    <us-gaap:NetInvestmentIncome contextRef="c4" decimals="0" id="ix_20_fact" unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:CryptoAssetRealizedGainLossOperatingAndNonoperating contextRef="c4" decimals="0" id="ix_21_fact" unitRef="usd">0</us-gaap:CryptoAssetRealizedGainLossOperatingAndNonoperating>
    <us-gaap:CryptoAssetUnrealizedGainLossOperatingAndNonoperating contextRef="c4" decimals="0" id="ix_22_fact" unitRef="usd">17563</us-gaap:CryptoAssetUnrealizedGainLossOperatingAndNonoperating>
    <us-gaap:NetIncomeLoss contextRef="c4" decimals="0" id="ix_23_fact" unitRef="usd">17563</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c4" decimals="0" id="ix_24_fact" unitRef="usd">2600000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c4" decimals="0" id="ix_25_fact" unitRef="usd">100000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:InvestmentCompanyIncreaseDecreaseFromShareTransaction contextRef="c4" decimals="0" id="ix_26_fact" unitRef="usd">2500000</us-gaap:InvestmentCompanyIncreaseDecreaseFromShareTransaction>
    <us-gaap:IncreaseDecreaseInOperatingCapital contextRef="c4" decimals="0" id="ix_27_fact" unitRef="usd">2517563</us-gaap:IncreaseDecreaseInOperatingCapital>
    <us-gaap:AssetsNet contextRef="c5" decimals="0" id="ix_28_fact" unitRef="usd">0</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c3" decimals="0" id="ix_29_fact" unitRef="usd">2517563</us-gaap:AssetsNet>
    <vavx:CryptoAssetNumberOfUnitsHeld
      contextRef="c3"
      decimals="INF"
      id="ix_30_fact"
      unitRef="Avalanche">206019.9</vavx:CryptoAssetNumberOfUnitsHeld>
    <us-gaap:CryptoAssetCost contextRef="c3" decimals="0" id="ix_31_fact" unitRef="usd">2500000</us-gaap:CryptoAssetCost>
    <us-gaap:CryptoAssetFairValue contextRef="c3" decimals="0" id="ix_32_fact" unitRef="usd">2517563</us-gaap:CryptoAssetFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c3"
      decimals="INF"
      id="ix_34_fact"
      unitRef="pure">1</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c3" decimals="0" id="ix_33_fact" unitRef="usd">2517563</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets
      contextRef="c3"
      decimals="INF"
      id="ix_36_fact"
      unitRef="pure">0</us-gaap:NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets>
    <us-gaap:NonInvestmentAssetsLessNonInvestmentLiabilities contextRef="c3" decimals="0" id="ix_35_fact" unitRef="usd">0</us-gaap:NonInvestmentAssetsLessNonInvestmentLiabilities>
    <vavx:NetAssetsPercentageOfNetAssetsValue
      contextRef="c3"
      decimals="INF"
      id="ix_38_fact"
      unitRef="pure">1</vavx:NetAssetsPercentageOfNetAssetsValue>
    <us-gaap:AssetsNet contextRef="c3" decimals="0" id="ix_37_fact" unitRef="usd">2517563</us-gaap:AssetsNet>
    <us-gaap:NatureOfOperations contextRef="c0" id="ixv-6542">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"&gt;&lt;b&gt;Note 1. Organization:&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"&gt;VanEck Avalanche ETF (the &#x201c;Trust&#x201d;), a Delaware statutory
trust, is an exchange-traded fund that issues common shares of beneficial interest in an ownership of the Trust (the &#x201c;Shares&#x201d;).
The Trust&#x2019;s investment objective is to reflect the performance of Avalanche (&#x201c;AVAX&#x201d;)&lt;span style="color: #E52138"&gt;
&lt;/span&gt;and rewards from staking a portion of the Trust&#x2019;s AVAX, to the extent VanEck Digital Assets, LLC (the &#x201c;Sponsor&#x201d;)
in its sole discretion determines that the Trust may do so without undue legal or regulatory risk, such as, without limitation,
by jeopardizing the Trust&#x2019;s ability to qualify as a grantor trust for tax purposes, less the operating expenses of the Trust. The
Trust is managed and controlled by the Sponsor, a wholly-owned subsidiary of Van Eck Associates Corporation (&#x201c;VanEck&#x201d;).
The CSC Delaware Trust Company, is the trustee of the Trust (the &#x201c;Trustee&#x201d;). The Trust commenced operations and began
listing on the NASDAQ Stock Market LLC on January 26, 2026.&lt;/p&gt;</us-gaap:NatureOfOperations>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c0" id="ixv-6551">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"&gt;&lt;b&gt;Note 2. Significant Accounting Policies:&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 36pt"&gt;A.&lt;/td&gt; &lt;td&gt;&lt;i&gt;Basis of Preparation and Use of Estimates&lt;/i&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;The preparation of financial statements in conformity with U.S.
generally accepted accounting principles (&#x201c;GAAP&#x201d;) requires management to make estimates and assumptions that affect
the reported amounts and disclosures in the financial statements. Actual results could differ from those estimates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;The Trust qualifies as an investment company solely for accounting
purposes and not for any other purpose and follows accounting and reporting requirements of Accounting Standards Codification (&#x201c;ASC&#x201d;)
Topic 946 Financial Services&#x2014;Investment Companies&lt;i&gt; &lt;/i&gt;(&#x201c;ASC Topic 946&#x201d;)&lt;i&gt;, &lt;/i&gt;but is not registered, and
is not required to be registered, as an investment company under the Investment Company Act of 1940, as amended.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 36pt"&gt;B.&lt;/td&gt; &lt;td&gt;&lt;i&gt;Cash&lt;/i&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 0"&gt;Cash, if any, represents cash deposits held at a major financial
institution and is subject to credit risk to the extent its balance exceeds the federally insured limits. As of December 31, 2025,
the Trust did not hold cash.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 36pt"&gt;C.&lt;/td&gt; &lt;td&gt;&lt;i&gt;Investment Valuation&lt;/i&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;The Trust values its investment in AVAX and other assets and liabilities
at fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction
between market participants on the measurement date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;The Trust identifies and determines the AVAX principal market (or
in the absence of a principal market, the most advantageous market) for GAAP financial statement purposes consistent with the application
of fair value measurement framework in Financial Accounting Standards Board (&#x201c;FASB&#x201d;) ASC 820 at 11:59 p.m. EST. Under
ASC 820, a principal market is the market with the greatest volume and activity level for the asset or liability. The Sponsor on
behalf of the Trust will determine in its sole discretion the valuation sources and policies used to prepare the Trust&#x2019;s
financial statements in accordance with GAAP.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;Various inputs are used in determining the fair value of assets
and liabilities. Inputs may be based on independent market data or they may be internally developed. These inputs are categorized
into a disclosure hierarchy consisting of three broad levels for financial reporting purposes. The three levels of the fair value
hierarchy are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;Level 1 &#x2013; Unadjusted quoted prices in active markets for identical
assets or liabilities;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;Level 2 &#x2013; Inputs other than quoted prices included within
Level 1 that are observable for the asset or liability either directly or indirectly, including quoted prices for similar assets
or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not considered
to be active, inputs other than quoted prices that are observable for the asset or liability, and inputs that are derived principally
from or corroborated by observable market data by correlation or other means; and&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;Level 3 &#x2013; Unobservable inputs where there are little or no
market activity for the asset or liability, including the Trust&#x2019;s assumptions used in determining the fair value of investments.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;The following is a summary of the fair value hierarchy as of December
31, 2025:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;December 31, 2025&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"&gt;Level 1&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"&gt;Level 2&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"&gt;Level 3&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;Assets&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 36pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Investment in AVAX&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="width: 8%; text-align: right; border-bottom: Black 3px double"&gt;2,517,563&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="width: 8%; text-align: right; border-bottom: Black 3px double"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="width: 8%; text-align: right; border-bottom: Black 3px double"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="width: 8%; text-align: right; border-bottom: Black 3px double"&gt;2,517,563&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;The following represents the changes in quantity of AVAX and the
respective fair value:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 88%; font: 10pt Times New Roman, Times, Serif; margin-left: 36pt; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1px; padding-left: 10pt; text-indent: -10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"&gt;AVAX&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"&gt;Fair&#160;Value&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(229,255,255)"&gt;
    &lt;td style="font-weight: bold; font-style: normal; padding-bottom: 1px; padding-left: 10pt; text-indent: -10pt"&gt;&lt;span style="font-style: normal"&gt;&lt;b&gt;Beginning balance as of November 20, 2025&lt;sup&gt;(a)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 1px solid"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 1px solid"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 1px solid"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 68%; text-align: left; padding-left: 10pt; text-indent: -10pt"&gt;AVAX purchased&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;206,019.90&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;2,500,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(229,255,255)"&gt;
    &lt;td style="text-align: left; padding-left: 10pt; text-indent: -10pt"&gt;AVAX sold&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 10pt; text-indent: -10pt"&gt;Net unrealized appreciation (depreciation) from investment in AVAX&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,563&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(229,255,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1px; padding-left: 10pt; text-indent: -10pt"&gt;Net realized loss on investment in AVAX&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 1px solid"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 1px solid"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; font-style: normal; padding-bottom: 3px; padding-left: 10pt; text-indent: -10pt"&gt;Ending balance as of December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 3px double"&gt;206,019.90&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 3px double"&gt;2,517,563&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 36pt"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 18pt"&gt;(a)&lt;/td&gt;&lt;td&gt;Date of seeding, the Trust did not hold any AVAX as of November 20, &lt;span style="-sec-ix-hidden: hidden-fact-1"&gt;2025&lt;/span&gt;.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table border="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 36pt"&gt;D.&lt;/td&gt; &lt;td&gt;&lt;i&gt;Avalanche&lt;/i&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;AVAX transactions are accounted for on trade date. Realized gains
and losses on the sale of AVAX are determined based on the average cost method. Under ASC Topic 946, the average cost method is
an accepted method to determine realized gains and losses on the sale of AVAX. Proceeds received by the Trust from the issuance
of baskets consist of AVAX. Deposits of AVAX will be held by Coinbase Custody Trust Company, LLC and/or Anchorage Digital Bank
N.A. (collectively the &#x201c;AVAX Custodians&#x201d;), on behalf of the Trust until (i) delivered out in connection with redemptions
of baskets or cash or (ii) sold by the Sponsor, which may be facilitated by the AVAX Custodians to pay fees due to the Sponsor
and Trust expenses and liabilities not assumed by the Sponsor.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;&#160;&#160;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="text-align: justify; width: 36pt"&gt;E.&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;i&gt;Calculation of Net Asset Value&lt;/i&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;The Trust&#x2019;s net asset value (&#x201c;NAV&#x201d;) is calculated
based on the Trust&#x2019;s net asset holdings, as reconciled to the AVAX Custodians&#x2019; accounts, on a market approach determined
on a daily basis using the MarketVector Avalanche Benchmark Rate price at 4:00 pm EST. The Trust&#x2019;s NAV per Share
is calculated by taking the current market value of its total assets, subtracting any liabilities, and then dividing that total
by the total number of outstanding Shares. The Trust Agreement gives the Sponsor the exclusive authority to determine the Trust&#x2019;s
NAV and the Trust&#x2019;s NAV per Share, which it has delegated to the Administrator.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="text-align: left; width: 36pt"&gt;F.&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;i&gt;Federal Income Taxes&lt;/i&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;The Trust is treated as a grantor trust for federal income tax purposes
and, therefore, no provision for federal income taxes is required. Any interest, expenses, gains and losses are passed through
to the holders of Shares of the Trust. The Sponsor has reviewed the tax positions for the period presented and has determined that
no provision for income tax is required in the Trust&#x2019;s financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="text-align: justify; width: 36pt"&gt;G.&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;i&gt;Segment Reporting&lt;/i&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;The Chief Financial Officer and Treasurer acts as the Trust&#x2019;s
chief operating decision maker (&#x201c;CODM&#x201d;), assessing performance and making decisions about resource allocation. The
CODM has determined that the Trust has a &lt;span style="-sec-ix-hidden: hidden-fact-2"&gt;single&lt;/span&gt; operating segment based on the fact that the Trust&#x2019;s long-term strategic
asset allocation is&lt;/p&gt;&lt;p style="font: 10pt Garamond, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;pre-determined in
accordance with the terms of its prospectus, with a defined investment strategy which is executed by the Sponsor.&lt;/span&gt;&lt;span style="font-family: Segoe UI,sans-serif; color: #03871A"&gt;
&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The financial information provided to and reviewed by the CODM is
presented within the Trust&#x2019;s financial statements.&lt;/span&gt;&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c0" id="ixv-6555">&lt;table border="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 36pt"&gt;A.&lt;/td&gt; &lt;td&gt;&lt;i&gt;Basis of Preparation and Use of Estimates&lt;/i&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;The preparation of financial statements in conformity with U.S.
generally accepted accounting principles (&#x201c;GAAP&#x201d;) requires management to make estimates and assumptions that affect
the reported amounts and disclosures in the financial statements. Actual results could differ from those estimates.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;The Trust qualifies as an investment company solely for accounting
purposes and not for any other purpose and follows accounting and reporting requirements of Accounting Standards Codification (&#x201c;ASC&#x201d;)
Topic 946 Financial Services&#x2014;Investment Companies&lt;i&gt; &lt;/i&gt;(&#x201c;ASC Topic 946&#x201d;)&lt;i&gt;, &lt;/i&gt;but is not registered, and
is not required to be registered, as an investment company under the Investment Company Act of 1940, as amended.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c0" id="ixv-6556">&lt;table border="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 36pt"&gt;A.&lt;/td&gt; &lt;td&gt;&lt;i&gt;Basis of Preparation and Use of Estimates&lt;/i&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;The preparation of financial statements in conformity with U.S.
generally accepted accounting principles (&#x201c;GAAP&#x201d;) requires management to make estimates and assumptions that affect
the reported amounts and disclosures in the financial statements. Actual results could differ from those estimates.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;The Trust qualifies as an investment company solely for accounting
purposes and not for any other purpose and follows accounting and reporting requirements of Accounting Standards Codification (&#x201c;ASC&#x201d;)
Topic 946 Financial Services&#x2014;Investment Companies&lt;i&gt; &lt;/i&gt;(&#x201c;ASC Topic 946&#x201d;)&lt;i&gt;, &lt;/i&gt;but is not registered, and
is not required to be registered, as an investment company under the Investment Company Act of 1940, as amended.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c0" id="ixv-6573">&lt;table border="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 36pt"&gt;B.&lt;/td&gt; &lt;td&gt;&lt;i&gt;Cash&lt;/i&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: 0"&gt;Cash, if any, represents cash deposits held at a major financial
institution and is subject to credit risk to the extent its balance exceeds the federally insured limits. As of December 31, 2025,
the Trust did not hold cash.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="c0" id="ixv-6583">&lt;table border="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 36pt"&gt;C.&lt;/td&gt; &lt;td&gt;&lt;i&gt;Investment Valuation&lt;/i&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;The Trust values its investment in AVAX and other assets and liabilities
at fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction
between market participants on the measurement date.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;The Trust identifies and determines the AVAX principal market (or
in the absence of a principal market, the most advantageous market) for GAAP financial statement purposes consistent with the application
of fair value measurement framework in Financial Accounting Standards Board (&#x201c;FASB&#x201d;) ASC 820 at 11:59 p.m. EST. Under
ASC 820, a principal market is the market with the greatest volume and activity level for the asset or liability. The Sponsor on
behalf of the Trust will determine in its sole discretion the valuation sources and policies used to prepare the Trust&#x2019;s
financial statements in accordance with GAAP.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;Various inputs are used in determining the fair value of assets
and liabilities. Inputs may be based on independent market data or they may be internally developed. These inputs are categorized
into a disclosure hierarchy consisting of three broad levels for financial reporting purposes. The three levels of the fair value
hierarchy are as follows:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;Level 1 &#x2013; Unadjusted quoted prices in active markets for identical
assets or liabilities;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;Level 2 &#x2013; Inputs other than quoted prices included within
Level 1 that are observable for the asset or liability either directly or indirectly, including quoted prices for similar assets
or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not considered
to be active, inputs other than quoted prices that are observable for the asset or liability, and inputs that are derived principally
from or corroborated by observable market data by correlation or other means; and&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;Level 3 &#x2013; Unobservable inputs where there are little or no
market activity for the asset or liability, including the Trust&#x2019;s assumptions used in determining the fair value of investments.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;The following is a summary of the fair value hierarchy as of December
31, 2025:&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;December 31, 2025&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"&gt;Level 1&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"&gt;Level 2&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"&gt;Level 3&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;Assets&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 36pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Investment in AVAX&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="width: 8%; text-align: right; border-bottom: Black 3px double"&gt;2,517,563&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="width: 8%; text-align: right; border-bottom: Black 3px double"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="width: 8%; text-align: right; border-bottom: Black 3px double"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="width: 8%; text-align: right; border-bottom: Black 3px double"&gt;2,517,563&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;The following represents the changes in quantity of AVAX and the
respective fair value:&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 88%; font: 10pt Times New Roman, Times, Serif; margin-left: 36pt; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1px; padding-left: 10pt; text-indent: -10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"&gt;AVAX&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"&gt;Fair&#160;Value&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(229,255,255)"&gt;
    &lt;td style="font-weight: bold; font-style: normal; padding-bottom: 1px; padding-left: 10pt; text-indent: -10pt"&gt;&lt;span style="font-style: normal"&gt;&lt;b&gt;Beginning balance as of November 20, 2025&lt;sup&gt;(a)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 1px solid"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 1px solid"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 1px solid"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 68%; text-align: left; padding-left: 10pt; text-indent: -10pt"&gt;AVAX purchased&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;206,019.90&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;2,500,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(229,255,255)"&gt;
    &lt;td style="text-align: left; padding-left: 10pt; text-indent: -10pt"&gt;AVAX sold&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 10pt; text-indent: -10pt"&gt;Net unrealized appreciation (depreciation) from investment in AVAX&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,563&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(229,255,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1px; padding-left: 10pt; text-indent: -10pt"&gt;Net realized loss on investment in AVAX&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 1px solid"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 1px solid"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; font-style: normal; padding-bottom: 3px; padding-left: 10pt; text-indent: -10pt"&gt;Ending balance as of December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 3px double"&gt;206,019.90&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 3px double"&gt;2,517,563&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 36pt"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 18pt"&gt;(a)&lt;/td&gt;&lt;td&gt;Date of seeding, the Trust did not hold any AVAX as of November 20, &lt;span style="-sec-ix-hidden: hidden-fact-1"&gt;2025&lt;/span&gt;.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="c0" id="ixv-6632">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;The following is a summary of the fair value hierarchy as of December
31, 2025:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;December 31, 2025&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"&gt;Level 1&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"&gt;Level 2&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"&gt;Level 3&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold"&gt;Assets&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 36pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Investment in AVAX&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="width: 8%; text-align: right; border-bottom: Black 3px double"&gt;2,517,563&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="width: 8%; text-align: right; border-bottom: Black 3px double"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="width: 8%; text-align: right; border-bottom: Black 3px double"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="width: 8%; text-align: right; border-bottom: Black 3px double"&gt;2,517,563&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:CryptoAssetFairValue contextRef="c6" decimals="0" id="ixv-7264" unitRef="usd">2517563</us-gaap:CryptoAssetFairValue>
    <us-gaap:CryptoAssetFairValue contextRef="c7" decimals="0" id="ixv-7265" unitRef="usd">0</us-gaap:CryptoAssetFairValue>
    <us-gaap:CryptoAssetFairValue contextRef="c8" decimals="0" id="ixv-7266" unitRef="usd">0</us-gaap:CryptoAssetFairValue>
    <us-gaap:CryptoAssetFairValue contextRef="c3" decimals="0" id="ixv-7267" unitRef="usd">2517563</us-gaap:CryptoAssetFairValue>
    <vavx:ChangesInQuantityOfAVAXAndRespectiveFairValueTableTextBlock contextRef="c0" id="ixv-6692">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;The following represents the changes in quantity of AVAX and the
respective fair value:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 88%; font: 10pt Times New Roman, Times, Serif; margin-left: 36pt; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1px; padding-left: 10pt; text-indent: -10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"&gt;AVAX&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"&gt;Fair&#160;Value&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(229,255,255)"&gt;
    &lt;td style="font-weight: bold; font-style: normal; padding-bottom: 1px; padding-left: 10pt; text-indent: -10pt"&gt;&lt;span style="font-style: normal"&gt;&lt;b&gt;Beginning balance as of November 20, 2025&lt;sup&gt;(a)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 1px solid"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 1px solid"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 1px solid"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 68%; text-align: left; padding-left: 10pt; text-indent: -10pt"&gt;AVAX purchased&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;206,019.90&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;2,500,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(229,255,255)"&gt;
    &lt;td style="text-align: left; padding-left: 10pt; text-indent: -10pt"&gt;AVAX sold&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 10pt; text-indent: -10pt"&gt;Net unrealized appreciation (depreciation) from investment in AVAX&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,563&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(229,255,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1px; padding-left: 10pt; text-indent: -10pt"&gt;Net realized loss on investment in AVAX&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 1px solid"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 1px solid"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; font-style: normal; padding-bottom: 3px; padding-left: 10pt; text-indent: -10pt"&gt;Ending balance as of December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 3px double"&gt;206,019.90&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 3px double"&gt;2,517,563&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 36pt"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 18pt"&gt;(a)&lt;/td&gt;&lt;td&gt;Date of seeding, the Trust did not hold any AVAX as of November 20, &lt;span style="-sec-ix-hidden: hidden-fact-1"&gt;2025&lt;/span&gt;.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</vavx:ChangesInQuantityOfAVAXAndRespectiveFairValueTableTextBlock>
    <vavx:CryptoAssetNumberOfUnitsHeld
      contextRef="c9"
      decimals="2"
      id="ix_39_fact"
      unitRef="Avalanche">0</vavx:CryptoAssetNumberOfUnitsHeld>
    <us-gaap:CryptoAssetFairValue contextRef="c10" decimals="0" id="ix_40_fact" unitRef="usd">0</us-gaap:CryptoAssetFairValue>
    <vavx:CryptoAssetNumberOfUnitsPurchased
      contextRef="c11"
      decimals="4"
      id="ixv-7270"
      unitRef="Avalanche">2060.199</vavx:CryptoAssetNumberOfUnitsPurchased>
    <us-gaap:CryptoAssetPurchase contextRef="c12" decimals="0" id="ixv-7271" unitRef="usd">2500000</us-gaap:CryptoAssetPurchase>
    <vavx:CryptoAssetNumberOfUnitsSold
      contextRef="c11"
      decimals="2"
      id="ixv-7272"
      unitRef="Avalanche">0</vavx:CryptoAssetNumberOfUnitsSold>
    <us-gaap:CryptoAssetSale contextRef="c12" decimals="0" id="ixv-7273" unitRef="usd">0</us-gaap:CryptoAssetSale>
    <us-gaap:CryptoAssetUnrealizedGainLossOperatingAndNonoperating contextRef="c12" decimals="0" id="ixv-7274" unitRef="usd">17563</us-gaap:CryptoAssetUnrealizedGainLossOperatingAndNonoperating>
    <us-gaap:CryptoAssetRealizedGainLossOperatingAndNonoperating contextRef="c12" decimals="0" id="ixv-7275" unitRef="usd">0</us-gaap:CryptoAssetRealizedGainLossOperatingAndNonoperating>
    <vavx:CryptoAssetNumberOfUnitsHeld
      contextRef="c13"
      decimals="4"
      id="ixv-7276"
      unitRef="Avalanche">2060.199</vavx:CryptoAssetNumberOfUnitsHeld>
    <us-gaap:CryptoAssetFairValue contextRef="c14" decimals="0" id="ixv-7277" unitRef="usd">2517563</us-gaap:CryptoAssetFairValue>
    <vavx:AvalanchePolicyTextBlock contextRef="c0" id="ixv-6781">&lt;table border="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 36pt"&gt;D.&lt;/td&gt; &lt;td&gt;&lt;i&gt;Avalanche&lt;/i&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;AVAX transactions are accounted for on trade date. Realized gains
and losses on the sale of AVAX are determined based on the average cost method. Under ASC Topic 946, the average cost method is
an accepted method to determine realized gains and losses on the sale of AVAX. Proceeds received by the Trust from the issuance
of baskets consist of AVAX. Deposits of AVAX will be held by Coinbase Custody Trust Company, LLC and/or Anchorage Digital Bank
N.A. (collectively the &#x201c;AVAX Custodians&#x201d;), on behalf of the Trust until (i) delivered out in connection with redemptions
of baskets or cash or (ii) sold by the Sponsor, which may be facilitated by the AVAX Custodians to pay fees due to the Sponsor
and Trust expenses and liabilities not assumed by the Sponsor.&lt;/p&gt;</vavx:AvalanchePolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c0" id="ixv-6791">&lt;table border="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="text-align: justify; width: 36pt"&gt;E.&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;i&gt;Calculation of Net Asset Value&lt;/i&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;The Trust&#x2019;s net asset value (&#x201c;NAV&#x201d;) is calculated
based on the Trust&#x2019;s net asset holdings, as reconciled to the AVAX Custodians&#x2019; accounts, on a market approach determined
on a daily basis using the MarketVector Avalanche Benchmark Rate price at 4:00 pm EST. The Trust&#x2019;s NAV per Share
is calculated by taking the current market value of its total assets, subtracting any liabilities, and then dividing that total
by the total number of outstanding Shares. The Trust Agreement gives the Sponsor the exclusive authority to determine the Trust&#x2019;s
NAV and the Trust&#x2019;s NAV per Share, which it has delegated to the Administrator.&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c0" id="ixv-6801">&lt;table border="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="text-align: left; width: 36pt"&gt;F.&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;i&gt;Federal Income Taxes&lt;/i&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;The Trust is treated as a grantor trust for federal income tax purposes
and, therefore, no provision for federal income taxes is required. Any interest, expenses, gains and losses are passed through
to the holders of Shares of the Trust. The Sponsor has reviewed the tax positions for the period presented and has determined that
no provision for income tax is required in the Trust&#x2019;s financial statements.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="c0" id="ixv-6811">&lt;table border="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="text-align: justify; width: 36pt"&gt;G.&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;i&gt;Segment Reporting&lt;/i&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;The Chief Financial Officer and Treasurer acts as the Trust&#x2019;s
chief operating decision maker (&#x201c;CODM&#x201d;), assessing performance and making decisions about resource allocation. The
CODM has determined that the Trust has a &lt;span style="-sec-ix-hidden: hidden-fact-2"&gt;single&lt;/span&gt; operating segment based on the fact that the Trust&#x2019;s long-term strategic
asset allocation is&lt;/p&gt;&lt;p style="font: 10pt Garamond, Times, Serif; margin: 0 0 0 36pt; text-indent: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;pre-determined in
accordance with the terms of its prospectus, with a defined investment strategy which is executed by the Sponsor.&lt;/span&gt;&lt;span style="font-family: Segoe UI,sans-serif; color: #03871A"&gt;
&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The financial information provided to and reviewed by the CODM is
presented within the Trust&#x2019;s financial statements.&lt;/span&gt;&lt;/p&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <vavx:TrustExpensesandOtherAgreementsTextBlock contextRef="c0" id="ixv-6854">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"&gt;&lt;b&gt;Note 3. Trust Expenses and Other Agreements&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"&gt;The Trust will pay the Sponsor a unified fee (the &#x201c;Sponsor
Fee&#x201d;) of 0.20% on average daily net assets, that accrues daily and pays monthly, beginning on January 26, 2026 (commencement
of operations). The Sponsor has agreed to waive that fee for the first $500 million in net assets up until February 28, 2026. The
Sponsor has agreed to pay all operating expenses (except for litigation expenses and other extraordinary expenses) out of the Sponsor
Fee. The Sponsor from time to time will sell AVAX, which may be facilitated by the custodian, in such quantity as is necessary
to permit payment of the Sponsor Fee and Trust expenses and liabilities not assumed by the Sponsor.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"&gt;The Trustee fee is paid by the Sponsor and is not an expense of
the Trust.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Garamond, Times, Serif; margin: 0; text-indent: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The Trust holds its
AVAX at the AVAX Custodians, both of which are regulated third-party custodians that carry insurance and are responsible for safekeeping
of AVAX owned by the Trust and holding private keys that provide access to the AVAX in the Trust&#x2019;s AVAX account.&lt;/span&gt;&lt;span style="font: 12pt Arial, Helvetica, Sans-Serif; color: #DB3326"&gt;
&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As of December 31, 2025 the Trust held all of its AVAX at Coinbase
Custody Trust Company, LLC.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"&gt;State Street Bank and Trust Company serves as the Trust&#x2019;s
administrator, transfer agent and cash custodian.&lt;/p&gt;</vavx:TrustExpensesandOtherAgreementsTextBlock>
    <vavx:SponsorFeeAtMonthlyRateOfAverageDailyNetAssets contextRef="c15" decimals="4" id="ixv-7278" unitRef="pure">0.002</vavx:SponsorFeeAtMonthlyRateOfAverageDailyNetAssets>
    <us-gaap:SponsorFees contextRef="c16" decimals="-6" id="ixv-7279" unitRef="usd">500000000</us-gaap:SponsorFees>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c0" id="ixv-6871">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"&gt;&lt;b&gt;Note 4. Related Parties&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"&gt;The Sponsor is considered to be a related party to the Trust.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"&gt;MarketVector Indexes GmbH is the index sponsor and index administrator
for the MarketVector Avalanche Benchmark Rate, which is used by the Trust to determine its NAV. MarketVector Indexes
GmbH is an indirectly wholly-owned subsidiary of VanEck.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"&gt;Van Eck Securities Corporation, a marketing agent to the Trust,
is a wholly-owned subsidiary of VanEck.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"&gt;VanEck was the initial seed investor (&#x201c;Seed Capital Investor&#x201d;)
and purchased for cash 4,000 Shares (the &#x201c;Seed Shares&#x201d;) at a per-Share price of $25.00 on November 20, 2025. Total
proceeds to the Trust from the sale of the Seed Shares were $100,000. On December 22 2025, the Seed Shares were redeemed for cash
and the Seed Capital Investor purchased the &#x201c;Seed Creation Baskets,&#x201d; comprising a total of 100,000 Shares at a per-Share
price of $25.00. Total proceeds to the Trust from the sale of the Seed Creation Baskets were $2,500,000 which resulted in the Trust
receiving 206,019.90 AVAX. As of December 31, 2025, the Seed Capital Investor&#x2019;s ownership in the Trust represents approximately
100% of net assets.&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c17"
      decimals="INF"
      id="ixv-7280"
      unitRef="shares">4000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c18"
      decimals="INF"
      id="ixv-7281"
      unitRef="usdPershares">25</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c19" decimals="0" id="ixv-7282" unitRef="usd">100000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SharesIssued
      contextRef="c20"
      decimals="INF"
      id="ixv-7283"
      unitRef="shares">100000</us-gaap:SharesIssued>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c20"
      decimals="INF"
      id="ixv-7284"
      unitRef="usdPershares">25</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c21" decimals="0" id="ixv-7285" unitRef="usd">2500000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <vavx:CryptoAssetNumberOfUnitsHeld
      contextRef="c20"
      decimals="2"
      id="ixv-7286"
      unitRef="Avalanche">206019.9</vavx:CryptoAssetNumberOfUnitsHeld>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c22" decimals="2" id="ixv-7287" unitRef="pure">1</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c0" id="ixv-6885">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"&gt;&lt;b&gt;Note 5. Capital Share Transactions&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"&gt;Investors can buy and sell Shares of the Trust in secondary market
transactions through brokers. Shares trade on the Exchange under the ticker symbol VAVX. Shares are bought and sold throughout
the trading day like other publicly traded securities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"&gt;The Trust continuously offers the Trust Shares in baskets consisting
of 25,000 Shares to authorized participants. Authorized participants pay a transaction fee for each order they place to create
or redeem one or more baskets. The Administrator calculates the cost to purchase (or sell in the case of a redemption order) the
amount of AVAX represented by the baskets being created (or redeemed); the amount of AVAX represented is equal to the combined
NAV of the number of Shares included in the baskets being created (or redeemed).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"&gt;The Trust creates and redeems Shares, but only in one or more baskets.
Baskets are only made in exchange for delivery to the Trust or the distribution by the Trust of the amount of AVAX represented
by the baskets being created or redeemed, the amount of which is equal to the combined NAV of the number of Shares included in
the baskets being created or redeemed determined as of 4:00 p.m. EST on the day the order to create or redeem baskets is properly
received. The authorized participants deliver cash or Avalanche to create baskets and receive cash or Avalanche when&lt;/p&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"&gt;redeeming Shares. For a subscription in cash, an authorized participant
will deliver cash to the Trust&#x2019;s account at the cash custodian, which the Sponsor will then use to purchase Avalanche from
a liquidity provider chosen by the Sponsor. For a redemption in cash, the Sponsor will arrange for the Avalanche represented by
the basket to be sold to a liquidity provider chosen by the Sponsor and the cash proceeds distributed from the Trust&#x2019;s account
at the cash custodian to the authorized participant. For an &#x201c;in-kind&#x201d; subscription, authorized participants will deliver,
or arrange for the delivery by the authorized participant&#x2019;s designee of, Avalanche to the Trust&#x2019;s account with the
Avalanche Custodian or Additional Avalanche Custodian in exchange for Shares when they purchase Shares. For an &#x201c;in-kind&#x201d;
redemption transaction with the Trust, when authorized participants redeem Shares, the Trust through the Avalanche Custodian or
the Additional Avalanche Custodian, will deliver Avalanche to such authorized participants, or a designee thereof, in exchange
for their Shares. Only authorized participants may place orders to create and redeem baskets through the transfer agent. The transfer
agent will coordinate with the Trust&#x2019;s AVAX Custodians to facilitate settlement of the Shares and AVAX.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"&gt;Share and capital activity is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 35%; font: 8pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid; white-space: nowrap;"&gt;&lt;b&gt;For the Period November &lt;br/&gt;
20, 2025 (Date of Seeding) &lt;br/&gt;
to December 31, 2025&lt;sup&gt;(a)&lt;/sup&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1px solid; font-weight: bold; text-align: center; padding-bottom: 1px"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1px solid; font-weight: bold; text-align: center; padding-bottom: 1px"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(229,255,255)"&gt;
    &lt;td&gt;Beginning of period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 48%"&gt;Shares issued&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 22%; text-align: right"&gt;104,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 22%; text-align: right"&gt;2,600,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(229,255,255)"&gt;
    &lt;td style="padding-bottom: 1px"&gt;Shares redeemed&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 1px solid"&gt;(4,000)&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 1px solid"&gt;(100,000)&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 3px"&gt;End of period&lt;/td&gt;&lt;td style="padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 3px double"&gt;100,000&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 3px double"&gt;2,500,000&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" style="width: 100%; font: 8pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 3%"&gt;(a)&lt;/td&gt; &lt;td style="width: 97%"&gt;No comparative share activity have been provided as the Trust did not have any operations as of December 31, 2024.&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c23"
      decimals="INF"
      id="ixv-7288"
      unitRef="shares">25000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ScheduleOfStockholdersEquityTableTextBlock contextRef="c0" id="ixv-6921">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"&gt;Share and capital activity is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 35%; font: 8pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid; white-space: nowrap;"&gt;&lt;b&gt;For the Period November &lt;br/&gt;
20, 2025 (Date of Seeding) &lt;br/&gt;
to December 31, 2025&lt;sup&gt;(a)&lt;/sup&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1px solid; font-weight: bold; text-align: center; padding-bottom: 1px"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1px solid; font-weight: bold; text-align: center; padding-bottom: 1px"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(229,255,255)"&gt;
    &lt;td&gt;Beginning of period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 48%"&gt;Shares issued&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 22%; text-align: right"&gt;104,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 22%; text-align: right"&gt;2,600,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(229,255,255)"&gt;
    &lt;td style="padding-bottom: 1px"&gt;Shares redeemed&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 1px solid"&gt;(4,000)&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 1px solid"&gt;(100,000)&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 3px"&gt;End of period&lt;/td&gt;&lt;td style="padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 3px double"&gt;100,000&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 3px double"&gt;2,500,000&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" style="width: 100%; font: 8pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 3%"&gt;(a)&lt;/td&gt; &lt;td style="width: 97%"&gt;No comparative share activity have been provided as the Trust did not have any operations as of December 31, 2024.&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityTableTextBlock>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c5"
      decimals="INF"
      id="ix_41_fact"
      unitRef="shares">0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValueOutstanding contextRef="c5" decimals="0" id="ix_42_fact" unitRef="usd">0</us-gaap:CommonStockValueOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c4"
      decimals="INF"
      id="ix_43_fact"
      unitRef="shares">104000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c4" decimals="0" id="ix_44_fact" unitRef="usd">2600000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="c4"
      decimals="INF"
      id="ix_45_fact"
      unitRef="shares">4000</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue contextRef="c4" decimals="0" id="ix_46_fact" unitRef="usd">100000</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c3"
      decimals="INF"
      id="ix_47_fact"
      unitRef="shares">100000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValueOutstanding contextRef="c3" decimals="0" id="ix_48_fact" unitRef="usd">2500000</us-gaap:CommonStockValueOutstanding>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c0" id="ixv-6992">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"&gt;&lt;b&gt;Note 6. Commitments and
Contingent Liabilities&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"&gt;In the normal course of business, the Trust enters into contracts
that contain a variety of general indemnifications. The Trust&#x2019;s maximum exposure under these agreements is unknown as this
would involve future claims that may be made against the Trust that have not yet occurred. However, the Sponsor believes the risk
of loss under these arrangements to be remote.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="c0" id="ixv-7000">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"&gt;&lt;b&gt;Note 7. Concentration Risk&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"&gt;Substantially all of the Trust&#x2019;s assets are holdings of AVAX,
which creates a concentration risk associated with fluctuations in the value of AVAX due to a number of factors. Accordingly, a
decline in the value of AVAX will have an adverse effect on the value of the Shares of the Trust. Factors that may have the effect
of causing a decline in the value of AVAX include high volatility, which could have a negative impact on the performance of the
Trust. AVAX platforms are relatively new and may be unregulated or may be subject to regulation in a relevant jurisdiction, but
may not be complying, and therefore, may be more exposed to fraud and security breaches than established, regulated exchanges for
other financial assets or instruments, which could have a negative impact on the performance of the Trust. The value of the Shares
depends on the development and acceptance of the avalanche network. The slowing or stopping of the development or acceptance of
the avalanche network may adversely affect an investment in the Trust. The price of AVAX on the AVAX market has exhibited periods
of extreme volatility. Digital assets such as AVAX were only introduced within the past decade, and the medium-to-long term value
of the Shares is subject to a number of factors relating to the capabilities and development of block-chain technologies and to
the fundamental investment characteristics of digital assets that are uncertain and difficult to evaluate. The Trust is subject
to risks due to its concentration of investments in a single asset class. Possible illiquid markets may exacerbate losses or increase
the variability between the Trust&#x2019;s NAV and its market price. The amount of AVAX represented by the Shares may decline over
time. AVAX with a fair value of $2,517,563 were held by the Coinbase Custody Trust Company, LLC at December 31, 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"&gt;Future and current regulations by a United States or foreign government
or quasi-governmental agency could have an adverse effect on an investment in the Trust. Shareholders do not have the protections
associated with ownership of Shares in an investment company registered under the 1940 Act or the protections afforded by the Commodity
Exchange Act. Future legal or regulatory developments may negatively affect the value of AVAX or require the Trust or the Sponsor
to become registered with the SEC or CFTC, which may cause the Trust to liquidate.&lt;/p&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"&gt;The Exchange on which the Shares are listed may halt trading in
the Trust&#x2019;s Shares, which would adversely impact a Shareholder&#x2019;s ability to sell Shares. The market infrastructure
of the AVAX spot market could result in the absence of active authorized participants able to support the trading activity of the
Trust.&lt;/p&gt;

&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"&gt;Shareholders that are not authorized participants may only purchase
or sell their Shares in secondary trading markets, and the conditions associated with trading in secondary markets may adversely
affect Shareholders&#x2019; investment in the Shares.&lt;/p&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:CryptoAssetFairValue contextRef="c24" decimals="0" id="ixv-7298" unitRef="usd">2517563</us-gaap:CryptoAssetFairValue>
    <us-gaap:SubsequentEventsTextBlock contextRef="c0" id="ixv-7038">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"&gt;&lt;b&gt;Note 8. Subsequent Event Review&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"&gt;The Trust has evaluated subsequent events and transactions for potential
recognition or disclosure through the date the financial statements were issued and has determined other than what has already
been disclosed in Note 1 and Note 3 that there are no other material events that would require disclosure.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:CommonStockSharesAuthorizedUnlimited contextRef="c4" id="hidden-fact-0">Unlimited</us-gaap:CommonStockSharesAuthorizedUnlimited>
    <vavx:YearOfInception contextRef="c4" id="hidden-fact-1">2025</vavx:YearOfInception>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c0"
      decimals="INF"
      id="hidden-fact-2"
      unitRef="Segment">1</us-gaap:NumberOfOperatingSegments>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-7304">0002060717</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c0" id="ixv-7305">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="c0" id="ixv-7306">FY</dei:DocumentFiscalPeriodFocus>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#hidden-fact-0"
          xlink:label="hidden-fact-0"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_6_fact"
          xlink:label="ix_6_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_5_fact"
          xlink:label="ix_5_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_2_fact"
          xlink:label="ix_2_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_4_fact"
          xlink:label="ix_4_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_7_fact"
          xlink:label="ix_7_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_8_fact"
          xlink:label="ix_8_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_0_fact"
          xlink:label="ix_0_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_3_fact"
          xlink:label="ix_3_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_1_fact"
          xlink:label="ix_1_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_9_fact"
          xlink:label="ix_9_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_0_footnote" xlink:label="ix_0_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-weight: normal">No com</xhtml:span>parative financial statements have been provided as the Trust did not have any operations as of December 31, 2024.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-0"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_6_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_5_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_2_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_4_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_7_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_8_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_0_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_3_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_1_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_9_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_12_fact"
          xlink:label="ix_12_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_10_fact"
          xlink:label="ix_10_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_18_fact"
          xlink:label="ix_18_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_16_fact"
          xlink:label="ix_16_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_15_fact"
          xlink:label="ix_15_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_17_fact"
          xlink:label="ix_17_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_11_fact"
          xlink:label="ix_11_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_14_fact"
          xlink:label="ix_14_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_13_fact"
          xlink:label="ix_13_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_19_fact"
          xlink:label="ix_19_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_1_footnote" xlink:label="ix_1_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">No comparative financial statements have been provided as the Trust did not have any operations as of December 31, 2024.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_12_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_10_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_18_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_16_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_15_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_17_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_11_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_14_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_13_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_19_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_21_fact"
          xlink:label="ix_21_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_20_fact"
          xlink:label="ix_20_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_26_fact"
          xlink:label="ix_26_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_22_fact"
          xlink:label="ix_22_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_25_fact"
          xlink:label="ix_25_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_27_fact"
          xlink:label="ix_27_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_24_fact"
          xlink:label="ix_24_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_28_fact"
          xlink:label="ix_28_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_29_fact"
          xlink:label="ix_29_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_23_fact"
          xlink:label="ix_23_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_2_footnote" xlink:label="ix_2_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-weight: normal">No comparative financial statements have been provided as the Trust did not have any operations
as of December 31, 2024.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_21_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_20_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_26_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_22_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_25_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_27_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_24_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_28_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_29_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_23_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_34_fact"
          xlink:label="ix_34_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_37_fact"
          xlink:label="ix_37_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_36_fact"
          xlink:label="ix_36_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_32_fact"
          xlink:label="ix_32_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_30_fact"
          xlink:label="ix_30_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_38_fact"
          xlink:label="ix_38_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_33_fact"
          xlink:label="ix_33_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_31_fact"
          xlink:label="ix_31_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_35_fact"
          xlink:label="ix_35_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_3_footnote" xlink:label="ix_3_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">No comparative financial statements have been provided as the Trust did not hold any avalanche as of December 31, 2024.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_34_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_37_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_36_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_32_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_30_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_38_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_33_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_31_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_35_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_40_fact"
          xlink:label="ix_40_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_39_fact"
          xlink:label="ix_39_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_4_footnote" xlink:label="ix_4_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Date of seeding, the Trust did not hold any AVAX as of November 20, <xhtml:span style="-sec-ix-hidden: hidden-fact-1">2025</xhtml:span>.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_40_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_39_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_42_fact"
          xlink:label="ix_42_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_47_fact"
          xlink:label="ix_47_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_48_fact"
          xlink:label="ix_48_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_41_fact"
          xlink:label="ix_41_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_44_fact"
          xlink:label="ix_44_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_46_fact"
          xlink:label="ix_46_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_43_fact"
          xlink:label="ix_43_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_45_fact"
          xlink:label="ix_45_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_5_footnote" xlink:label="ix_5_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">No comparative share activity have been provided as the Trust did not have any operations as of December 31, 2024.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_42_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_47_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_48_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_41_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_44_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_46_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_43_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_45_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
